(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma

BACKGROUND: To evaluate (106)Ruthenium Brachytherapy in management of medium sized uveal melanoma, with emphasis on 5-year outcome and toxicity. METHODS: From April 2007 to October 2015, 39 patients with medium sized uveal melanoma were treated with 106 Ru eye plaques brachytherapy. At the time of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ping, Purtskhvanidze, Konstantine, Kandzia, Gerit, Neumann, Dirk, Luetzen, Ulf, Siebert, Frank-André, Roider, Johann, Dunst, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392724/
https://www.ncbi.nlm.nih.gov/pubmed/32727533
http://dx.doi.org/10.1186/s13014-020-01621-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392724/
https://www.ncbi.nlm.nih.gov/pubmed/32727533
http://dx.doi.org/10.1186/s13014-020-01621-4

Ejemplares similares